Skip to main content
Erschienen in: International Urology and Nephrology 8/2017

15.05.2017 | Urology - Original Paper

The significance of histological analysis following laser transurethral resection of the prostate

verfasst von: Shady Nafie, John Dormer, Masood A. Khan

Erschienen in: International Urology and Nephrology | Ausgabe 8/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Monopolar transurethral resection of the prostate is the gold standard for the treatment of benign prostatic hyperplasia. However, due to the associated risks of bleeding and TUR syndrome, laser prostate surgery is gaining popularity. We perform thulium-laser vaporesection of the prostate (TmLRP), where histological samples are generated in every case. We determined postoperative incidence and significance of prostate cancer detection, by retrospective histological examination of our cases.

Methodology

Between October 2006 and August 2012, 223 patients underwent TmLRP by a single surgeon in our institution. With a background of a benign DRE, and no suspicion of CaP, histological results were studied.

Results

Mean age was 71 years (range 46–91), mean PSA was 4.1 ng/mL (range 0.1–20). 4.9% (11/223) had cancer prostate (CaP) diagnosed, with mean PSA of 6.9 ng/mL (range 0.7–14). Of these: 91% (10/11) had pT1b disease while 9% (1/11) had pT1a disease. Gleason score was 6 in 28% (3/11); 7 in 36% (4/11); 8 in 18% (2/11); 9 in and 18% (2/11).

Conclusion

4.9% of patients had unexpected CaP, with significant disease in 4.4% (pT1b) and 3.6% (Gleason score ≥7). Hence, patients should be advised of the small risk of missing significant unsuspected CaP after laser prostatectomy.
Literatur
1.
Zurück zum Zitat Chisholm GD (1989) Benign prostatic hyperplasia: the best treatment. BMJ Br Med J 299:215CrossRef Chisholm GD (1989) Benign prostatic hyperplasia: the best treatment. BMJ Br Med J 299:215CrossRef
4.
Zurück zum Zitat Karatas OF, Alkan E, Horasanli K et al (2010) Photoselective vaporization of the prostate in men with a history of chronic oral anti-coagulation. Int Braz J Urol 36:190–197CrossRefPubMed Karatas OF, Alkan E, Horasanli K et al (2010) Photoselective vaporization of the prostate in men with a history of chronic oral anti-coagulation. Int Braz J Urol 36:190–197CrossRefPubMed
9.
10.
Zurück zum Zitat Kitamura H, Masumori N, Tanuma Y et al (2002) Does transurethral resection of the prostate facilitate detection of clinically significant prostate cancer that is missed with systematic sextant and transition zone biopsies? Int J Urol 9:95–99CrossRefPubMed Kitamura H, Masumori N, Tanuma Y et al (2002) Does transurethral resection of the prostate facilitate detection of clinically significant prostate cancer that is missed with systematic sextant and transition zone biopsies? Int J Urol 9:95–99CrossRefPubMed
11.
Zurück zum Zitat Zigeuner RE, Lipsky K, Riedler I et al (2003) Did the rate of incidental prostate cancer change in the era of PSA testing? A retrospective study of 1127 patients. Urology 62:451–455CrossRefPubMed Zigeuner RE, Lipsky K, Riedler I et al (2003) Did the rate of incidental prostate cancer change in the era of PSA testing? A retrospective study of 1127 patients. Urology 62:451–455CrossRefPubMed
12.
Zurück zum Zitat Sj B, Ds C, Pc W, Ll E (1984) The development of human benign prostatic hyperplasia with age. J Urol 132:474–479CrossRef Sj B, Ds C, Pc W, Ll E (1984) The development of human benign prostatic hyperplasia with age. J Urol 132:474–479CrossRef
15.
Zurück zum Zitat Al-Ansari A, Younes N, Sampige VP et al (2010) GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm follow-up. 58:349–355. doi:10.1016/j.eururo.2010.05.026 Al-Ansari A, Younes N, Sampige VP et al (2010) GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm follow-up. 58:349–355. doi:10.​1016/​j.​eururo.​2010.​05.​026
16.
Zurück zum Zitat Pal RP, Khan MA (2012) Intermediate-term efficacy of Tm:YAG laser prostate vaporesection for bladder outlet obstruction: initial experience from a UK teaching hospital. Urol Int 88:39–42. doi:10.1159/000330901 CrossRefPubMed Pal RP, Khan MA (2012) Intermediate-term efficacy of Tm:YAG laser prostate vaporesection for bladder outlet obstruction: initial experience from a UK teaching hospital. Urol Int 88:39–42. doi:10.​1159/​000330901 CrossRefPubMed
17.
Zurück zum Zitat Trueman P, Hood SC, Nayak US, Mrazek MF (1999) Prevalence of lower urinary tract symptoms and self-reported diagnosed ‘benign prostatic hyperplasia’, and their effect on quality of life in a community-based survey of men in the UK. BJU Int 83:410–441CrossRefPubMed Trueman P, Hood SC, Nayak US, Mrazek MF (1999) Prevalence of lower urinary tract symptoms and self-reported diagnosed ‘benign prostatic hyperplasia’, and their effect on quality of life in a community-based survey of men in the UK. BJU Int 83:410–441CrossRefPubMed
Metadaten
Titel
The significance of histological analysis following laser transurethral resection of the prostate
verfasst von
Shady Nafie
John Dormer
Masood A. Khan
Publikationsdatum
15.05.2017
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 8/2017
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-017-1617-8

Weitere Artikel der Ausgabe 8/2017

International Urology and Nephrology 8/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.